NO954188L - Modifisert-protein- og -peptid - farmasöytika - Google Patents

Modifisert-protein- og -peptid - farmasöytika

Info

Publication number
NO954188L
NO954188L NO954188A NO954188A NO954188L NO 954188 L NO954188 L NO 954188L NO 954188 A NO954188 A NO 954188A NO 954188 A NO954188 A NO 954188A NO 954188 L NO954188 L NO 954188L
Authority
NO
Norway
Prior art keywords
amino acid
modified
partial
positions
complete
Prior art date
Application number
NO954188A
Other languages
English (en)
Norwegian (no)
Other versions
NO954188D0 (no
Inventor
Irving Boime
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of NO954188D0 publication Critical patent/NO954188D0/no
Publication of NO954188L publication Critical patent/NO954188L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO954188A 1993-04-20 1995-10-19 Modifisert-protein- og -peptid - farmasöytika NO954188L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4986993A 1993-04-20 1993-04-20
PCT/US1994/004069 WO1994024148A1 (en) 1993-04-20 1994-04-13 Modified protein and peptide pharmaceuticals

Publications (2)

Publication Number Publication Date
NO954188D0 NO954188D0 (no) 1995-10-19
NO954188L true NO954188L (no) 1995-12-19

Family

ID=21962168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954188A NO954188L (no) 1993-04-20 1995-10-19 Modifisert-protein- og -peptid - farmasöytika

Country Status (14)

Country Link
EP (1) EP0695307B1 (de)
JP (2) JP4156024B2 (de)
AT (1) ATE187740T1 (de)
AU (1) AU687053B2 (de)
CA (1) CA2160800C (de)
DE (1) DE69422169D1 (de)
ES (1) ES2141229T3 (de)
FI (1) FI954978A7 (de)
GR (1) GR3032775T3 (de)
NO (1) NO954188L (de)
NZ (1) NZ265529A (de)
PT (1) PT695307E (de)
WO (1) WO1994024148A1 (de)
ZA (1) ZA942729B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
JP2001333772A (ja) 2000-04-25 2001-12-04 Washington Univ 可変性の活性を有する単鎖稔性ホルモン
ATE320449T1 (de) * 2000-12-11 2006-04-15 Cheil Jedang Corp Fusionsprotein mit verbesserter in vivo erythropoietinwirkung
US6987172B2 (en) 2001-03-05 2006-01-17 Washington University In St. Louis Multifunctional single chain glycoprotein hormones comprising three or more β subunits
KR100467751B1 (ko) * 2001-12-03 2005-01-24 씨제이 주식회사 생체내 에리스로포이에틴 활성이 증진된 융합단백질
US8048849B2 (en) 2006-02-03 2011-11-01 Modigene, Inc. Long-acting polypeptides and methods of producing same
US20150038413A1 (en) 2006-02-03 2015-02-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8450269B2 (en) 2006-02-03 2013-05-28 Prolor Biotech Ltd. Long-acting growth hormone and methods of producing same
US20140113860A1 (en) 2006-02-03 2014-04-24 Prolor Biotech Ltd. Long-acting polypeptides and methods of producing and administering same
US7553941B2 (en) 2006-02-03 2009-06-30 Modigene Inc Long-acting polypeptides and methods of producing same
US9249407B2 (en) 2006-02-03 2016-02-02 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US8304386B2 (en) 2006-02-03 2012-11-06 Prolor Biotech, Inc. Long-acting growth hormone and methods of producing same
US8476234B2 (en) 2006-02-03 2013-07-02 Prolor Biotech Inc. Long-acting coagulation factors and methods of producing same
US10221228B2 (en) 2006-02-03 2019-03-05 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US8048848B2 (en) 2006-02-03 2011-11-01 Prolor Biotech Ltd. Long-acting interferons and derivatives thereof and methods thereof
US10351615B2 (en) 2006-02-03 2019-07-16 Opko Biologics Ltd. Methods of treatment with long-acting growth hormone
US8946155B2 (en) 2006-02-03 2015-02-03 Opko Biologics Ltd. Long-acting polypeptides and methods of producing and administering same
US9458444B2 (en) 2006-02-03 2016-10-04 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
US9663778B2 (en) 2009-07-09 2017-05-30 OPKO Biologies Ltd. Long-acting coagulation factors and methods of producing same
US12203113B2 (en) 2009-07-09 2025-01-21 Opko Biologics Ltd. Long-acting coagulation factors and methods of producing same
JP2015520128A (ja) 2012-04-19 2015-07-16 オプコ バイオロジクス リミテッド 長時間作用性オキシントモジュリン変異体とその作製方法
ES2882890T3 (es) 2012-11-20 2021-12-03 Opko Biologics Ltd Método para aumentar el volumen hidrodinámico de polipéptidos mediante la unión a péptidos carboxi terminales de la gonadotrofina
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
US20150158926A1 (en) 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
WO2016092550A2 (en) * 2014-12-10 2016-06-16 Opko Biologics Ltd. Methods of producing long acting ctp-modified polypeptides
EP3988113A1 (de) 2015-06-19 2022-04-27 OPKO Biologics Ltd. Gerinnungsfaktoren mit langzeitwirkung und verfahren zur herstellung davon
BR112019000610A2 (pt) 2016-07-11 2019-07-02 Opko Biologics Ltd fator vii de coagulação de longa ação e métodos de produção do mesmo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4654324A (en) * 1981-08-27 1987-03-31 Eli Lilly And Company Human proinsulin pharmaceutical formulations
US4959455A (en) * 1986-07-14 1990-09-25 Genetics Institute, Inc. Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
US6225449B1 (en) * 1991-10-04 2001-05-01 Washington University Hormone analogs with multiple CTP extensions
AU648020B2 (en) * 1989-02-21 1994-04-14 Washington University Modified forms of reproductive hormones
JPH04156024A (ja) * 1990-10-19 1992-05-28 Fujitsu Ltd サブレート交換方式

Also Published As

Publication number Publication date
GR3032775T3 (en) 2000-06-30
FI954978L (fi) 1995-11-15
AU6633194A (en) 1994-11-08
EP0695307A4 (de) 1996-08-21
CA2160800A1 (en) 1994-10-27
ATE187740T1 (de) 2000-01-15
NZ265529A (en) 1998-01-26
JPH08509218A (ja) 1996-10-01
ZA942729B (en) 1995-01-09
WO1994024148A1 (en) 1994-10-27
DE69422169D1 (de) 2000-01-20
CA2160800C (en) 2010-06-01
AU687053B2 (en) 1998-02-19
EP0695307A1 (de) 1996-02-07
JP4156024B2 (ja) 2008-09-24
PT695307E (pt) 2000-05-31
FI954978A0 (fi) 1995-10-18
JP2008133295A (ja) 2008-06-12
FI954978A7 (fi) 1995-11-15
ES2141229T3 (es) 2000-03-16
EP0695307B1 (de) 1999-12-15
NO954188D0 (no) 1995-10-19

Similar Documents

Publication Publication Date Title
NO954188L (no) Modifisert-protein- og -peptid - farmasöytika
NO941186D0 (no) Hormonanaloger med multiple CTP-forlengelser
NO950939D0 (no) Defektive adenovirusvektorer og deres anvendelse i gene-terapien
NO952744D0 (no) Cytokinbegrensende midler
DK0597033T3 (da) IGF-1 til forbedring af den neurale tilstand
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
DK1019073T3 (da) Apoliprotein A-I agonister og deres anvendelse til at behandle dyslipidæmiske lidelser
ATE293700T1 (de) Adenovirus mit glutathion peroxydate gene
DK0601154T3 (da) BPC-peptider, deres fremstilling og anvendelse
DK1775346T3 (da) Disulfid-tværbundne glycoproteinhormonanaloger, deres fremstilling og anvendelse
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
GR3034309T3 (en) IFN--g(b) LIQUID FORMULATIONS
PT88539A (pt) Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
DE60036555D1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
DE69524388D1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
DE69502380D1 (de) 4-aminoderivate von 5-substituierten mycophenolsäuren
DK107389D0 (da) Modificerede proteiner
DK0637956T3 (da) Anvendelse af remacemid til behandling af Parkinsonˆs sygdom
RU97105543A (ru) Способ лечения шейного остеохондроза с сопутствующим синдромом позвоночной артерии
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio
TH18599A (th) ยาที่เป็นโปรตีนและเพทไทด์ดัดแปลง
DE69123242D1 (de) Physiologisch aktive Peptide, ihre Verwendung und eine Methode besagte Peptide herzustellen
RU96118184A (ru) Способ лечения рефлекторных синдромов при остеохондрозе
NO893572L (no) Lunge-overflateaktivt protein og beslektet polypeptid.
RU97107442A (ru) Способ коррекции дислипопротеидемии

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application